Search results for: chemistry & pharma

Chemistry & Pharma

Whether it is visible or not, chemistry is a driving factor in nearly every field of industry – not least pharmaceuticals.  As both qualified scientists and highly experienced patent attorn...

The Influence of Artificial Intelligence on the Pharmaceutical Pipeline

On Wednesday 5th June, Gill Jennings & Every hosted an event to investigate how Artificial Intelligence (AI) and Machine Learning (ML) are transforming digital healthcare and pharmaceuticals. &nbs...

GJE announces senior associate promotions

GJE is delighted to announce that Ash Earl and Philippa Makepeace have been promoted to senior associate. Both are patent attorneys in the firm’s Chemistry & Life Sciences team. Ash Earl joined ...

GJE proud to be ranked consistently at No. 1 by the Financial Times

GJE is proud to have been recognised with the highest possible rankings by the Financial Times in its 2024 survey of Europe’s leading patent law firms. We are the only firm to have been ranked at No...

Milan confirmed as UPC Central Division Seat by Italian Ministry of Foreign Affairs

Last week, on 26 January 2024, the Italian Ministry of Foreign Affairs and International Cooperation announced that the UPC Headquarters Agreement has now been signed between Italy and the Unified Pat...

Biotech Buddies London | 14.03.2024

Thursday 14 March 2024 I 6:00 pm (London UK – GMT) GJE look forward to hosting the next Biotech Buddies networking event at our office in Broadgate Tower. Several members of our chemistry and life s...

GJE’s Arnie Clarke and Michael Lord have both been listed as a ‘recommended individuals’ in the JUVE Patent UK Rankings 2024.

JUVE is a publisher based in Cologne, Germany, that has been reporting on the UPC, the European Patent Office and developments at law firms and in-house departments for twenty years. They provide dail...

CASGEVY™/Exa-cel: UK Approves World’s First Gene Therapy for Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

On 16 November 2023, the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK approved the world’s first CRISPR-based gene therapy, which is also the first gene therapy for the treat...

GJE Recognised by Chambers and Partners 2024

We are pleased to be recognised in the 2024 Chambers and Partners guide. Chambers and Partners identifies the best law firms globally through interviews and client feedback.  The directory a...

GJE No.1 in the Financial Times’ “Europe’s Leading Patent Firms 2023” Awards

It brings us great pride to announce that GJE has been listed first place on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2023” annual awards.  GJ...